Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-09-12 | Dr. Joseph Keegan currently serves as a director and advisor for Interspace Diagnostics... Two new director nominees, Dr. Alpna Seth and Dr. Joseph Keegan, are being nominated for the first time this year. |
| Filing Date | Source Excerpt |
|---|---|
| 2016-06-22 | Dr. Keegan was appointed to the Board effective January 1, 2016 and was subsequently appointed Chairman of our Audit Committee. No specific compensation amount stated. |
| 2017-08-14 | Joseph Keegan, Ph.D. was appointed to the Board effective January 1, 2016 and was subsequently appointed Chairman of our Audit Committee and our Nominating and Corporate Governance Committee. Dr. Keegan27s fees represent the annual director27s fee then in effect of $40,000, plus the $25,000 Chair of the Audit Committee fee, and a fee of $5,000 for serving on multiple committees. |
| 2018-04-30 | Dr. Keegan’s fees represent the annual director’s fee of $30,000, plus the $15,000 Chair of the Audit Committee fee, plus the $5,000 Chair of the Nominating Committee fee, and a fee of $5,000 for serving on multiple committees. |
| 2019-08-22 | Joseph Keegan, Ph.D. was appointed to the Board effective January 1, 2016 and was subsequently appointed Chairman of our Audit Committee and our Nominating Committee. The following table presents information relating to total compensation for our non-employee directors for the year ended December 31, 2018. Joseph Keegan: Fees earned ($) 55,000, Stock awards ($) 4,848, Option awards ($) 17,280, Total ($) 77,128. |
| 2020-06-10 | Joseph Keegan, Ph.D. was appointed to the Board effective January 1, 2016 and was subsequently appointed Chairman of our Audit Committee and our Nominating Committee. Dr. Keegan has more than 30 years of experience in life science businesses. From 2007 to 2012, when it was sold to Pall Corporation, Dr. Keegan was chief executive officer at ForteBio, Inc., a life science tool company, where he helped to lead a financing round and established product development and sales strategies for that company. |
| 2021-09-27 | Joseph Keegan, Ph.D. was appointed to the Board effective January 1, 2016 and was subsequently appointed Chairman of our Audit Committee and our Nominating Committee. Director Compensation in 2020 Joseph Keegan Fees earned or paid in cash: $51,250 Stock awards: $0 Option awards: $134,792 All other compensation: $0 Total: $186,042. |
| 2024-09-20 | Joseph Keegan, Ph.D. was appointed to the Board effective January 1, 2016 and was subsequently appointed Chairman of our Audit Committee and our Nominating Committee... The Audit Committee is currently comprised of Dr. Keegan (Chairperson), Mr. Sullivan and Mr. Rocca... The following table presents information relating to total compensation for our non-employee directors for the year ended December 31, 2023... Joseph Keegan 50,000 - 50,000 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22